brodalumab
Selected indexed studies
- Brodalumab. (, 2006) [PMID:29999957]
- Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis. (Drugs Today (Barc), 2023) [PMID:36847624]
- Brodalumab. (, 2012) [PMID:31643345]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Brodalumab. (2006) pubmed
- Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis. (2023) pubmed
- Brodalumab. (2012) pubmed
- Brodalumab: A Review of Safety. (2018) pubmed
- Brodalumab for the treatment of plaque psoriasis: up-to-date. (2019) pubmed
- Brodalumab. (2026) pubmed
- Brodalumab: 4-Year US Pharmacovigilance Report. (2023) pubmed
- Brodalumab for the treatment of psoriasis. (2016) pubmed
- The safety of brodalumab for the treatment of psoriasis. (2020) pubmed
- Brodalumab in psoriasis: evidence to date and clinical potential. (2019) pubmed